These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9298205)

  • 1. Useful vectors for the two-hybrid system in mammalian cells.
    Buchert M; Schneider S; Adams MT; Hefti HP; Moelling K; Hovens CM
    Biotechniques; 1997 Sep; 23(3):396-8, 400, 402. PubMed ID: 9298205
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system.
    Luo Y; Batalao A; Zhou H; Zhu L
    Biotechniques; 1997 Feb; 22(2):350-2. PubMed ID: 9043710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong transcriptional activators isolated from viral DNA by the 'activator trap', a novel selection system in mammalian cells.
    Gstaiger M; Schaffner W
    Nucleic Acids Res; 1994 Oct; 22(20):4031-8. PubMed ID: 7937127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins.
    Melcher K
    J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of protein-protein interactions using different vectors in the two-hybrid system.
    Legrain P; Dokhelar MC; Transy C
    Nucleic Acids Res; 1994 Aug; 22(15):3241-2. PubMed ID: 8065941
    [No Abstract]   [Full Text] [Related]  

  • 6. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial control of transcription: the herpes simplex virus VP16-induced complex.
    Wilson AC; Cleary MA; Lai JS; LaMarco K; Peterson MG; Herr W
    Cold Spring Harb Symp Quant Biol; 1993; 58():167-78. PubMed ID: 7956027
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical mechanism of transcriptional activation by GAL4-VP16.
    Tantin D; Chi T; Hori R; Pyo S; Carey M
    Methods Enzymol; 1996; 274():133-49. PubMed ID: 8902801
    [No Abstract]   [Full Text] [Related]  

  • 10. GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.
    Stafford GA; Morse RH
    Mol Cell Biol; 2001 Jul; 21(14):4568-78. PubMed ID: 11416135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloramphenicol acetyltransferase expression as a sensor for fusion activity.
    Gicklhorn D; Eickmann M; Radsak K
    Biotechniques; 1999 Nov; 27(5):902-4, 906, 908. PubMed ID: 10572633
    [No Abstract]   [Full Text] [Related]  

  • 12. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain.
    Herr W; Cleary MA
    Genes Dev; 1995 Jul; 9(14):1679-93. PubMed ID: 7622033
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcriptional activation by recombinant GAL4-VP16 in the Xenopus oocyte.
    Xu L; Schaffner W; Rungger D
    Nucleic Acids Res; 1993 Jun; 21(11):2775. PubMed ID: 8332481
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
    Ghosh S; Selby MJ; Peterlin BM
    J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for two modes of cooperative DNA binding in vivo that do not involve direct protein-protein interactions.
    Vashee S; Melcher K; Ding WV; Johnston SA; Kodadek T
    Curr Biol; 1998 Apr; 8(8):452-8. PubMed ID: 9550700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refinement of vectors for use in the yeast two-hybrid system.
    Roder KH; Wolf SS; Schweizer M
    Anal Biochem; 1996 Oct; 241(2):260-2. PubMed ID: 8921196
    [No Abstract]   [Full Text] [Related]  

  • 18. B-MYB transactivates its own promoter through SP1-binding sites.
    Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
    Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trans-acting peptide activates the yeast a1 repressor by raising its DNA-binding affinity.
    Stark MR; Escher D; Johnson AD
    EMBO J; 1999 Mar; 18(6):1621-9. PubMed ID: 10075932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and protein interaction assays of the VP16C transcription activation domain.
    Nedialkov YA; Shooltz DD; Triezenberg SJ
    Methods Enzymol; 2003; 370():522-35. PubMed ID: 14712672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.